上海康鹏科技股份有限公司对外担保管理制度 第七条 公司发生对外担保事项时，应当经董事会审议后及时对外披露。对 外提供担保事项属于下列情形的，还应当在董事会审议通过后提交股东会审议： （一）单笔担保额超过公司最近一期经审计净资产 10%的担保； （二）公司及公司控股子公司的对外担保总额，超过公司最近一期经审计净 资产的 50%以后提供的任何担保； （三）为资产负债率超过 70%的担保对象提供的担保； （四）按照担保金额连续 12 个月内累计计算原则，超过公司最近一期经审 计总资产 30%的担保； （五）公司及其控股子公司对外提供的担保总额，超过公司最近一期经审计 总资产 30%以后提供的任何担保； （六）对公司股东、实际控制人及其关联方提供的担保； （七）证券交易所或者公司章程规定的其他担保情形。 公司为全资子公司提供担保，或者为控股子公司提供担保且控股子公司其他 股东按所享有的权益提供同等比例担保，不损害公司利益的，可以豁免适用前款 第一项至第三项的规定，但是公司章程另有规定除外。公司应当在年度报告和半 年度报告中汇总披露前述担保。 对于董事会权限范围内的担保事项，除应当经全体董事的过半数通过外，还 必须经出 ...

证券代码：688602 证券简称：康鹏科技 公告编号：2025-050 上海康鹏科技股份有限公司 关于为他人提供反担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 上海康鹏科技股份有限公司（以下简称"公司"或"康鹏科技"）的参股公 司浙江中硝康鹏化学有限公司（以下简称"中硝康鹏"）为满足日常经营发展的 融资需要，向三井住友银行（中国）有限公司杭州分行（以下简称"住友银行"） 拟申请不超过人民币 9,000.00 万元贷款额度，其控股股东中央硝子株式会社（以 下简称"中央硝子"）为上述贷款本金、利息、损害金及其他根据贷款合同承担 的全部债务（以下简称"融资担保合计金额"）提供连带责任保证担保，公司及 其控股子公司衢州康鹏化学有限公司（以下简称"衢州康鹏"）合计持有中硝康 鹏 40%的股权，公司拟按照其在中硝康鹏的持股比例就融资担保合计金额的 40% 向中央硝子提供相应的反担保。 （二）内部决策程序 公司于 2025 年 8 月 25 日召开第三届董事会第六次会议，审议通过了《关于 为他人提供反担保的议案 ...

中信建投证券股份有限公司 关于上海康鹏科技股份有限公司 使用部分闲置募集资金进行现金管理的核查意见 中信建投证券股份有限公司（以下简称"中信建投证券"、"保荐人"）作 为上海康鹏科技股份有限公司（以下简称"公司"、"康鹏科技"）首次公开发 行股票并在科创板上市的保荐人，根据《证券发行上市保荐业务管理办法》《上 海证券交易所科创板股票上市规则》《上市公司募集资金监管规则》和《上海证 券交易所科创板上市公司自律监管指引第 1 号——规范运作》等相关规定，对康 鹏科技使用部分闲置募集资金进行现金管理的事项进行了核查，具体情况如下： 一、募集资金基本情况 根据中国证券监督管理委员会《关于同意上海康鹏科技股份有限公司首次公 开发行股票注册的批复》(证监许可[2023]1007 号)，公司首次公开发行人民币普 通股 103,875,000 股，发行价格为每股人民币 8.66 元，共募集资金人民币 899,557,500.00 元，扣除承销保荐费用人民币 60,969,025.00 元(不含增值税)后的 募集资金为人民币 838,588,475.00 元，上述募集资金于 2023 年 7 月 17 日存入公 司募集资金账户 ...

Core Viewpoint - The company has approved the use of idle raised funds for cash management, aiming to enhance fund utilization efficiency while ensuring the safety and proper use of the funds [1][13]. Fundraising Overview - The company raised a total of RMB 899.56 million through its initial public offering, with a net amount of RMB 810.66 million after deducting underwriting fees and other expenses [1][2]. - The funds are managed in a dedicated account under a tripartite supervision agreement with the sponsor and the supervising bank [2]. Cash Management Plan - The company plans to use up to RMB 650 million of idle raised funds for cash management, with a maximum investment period of 12 months [3][5]. - The investment products will include high-security, liquid, and capital-protected options such as time deposits, large certificates of deposit, structured deposits, and guaranteed income certificates from brokers [5][8]. Implementation and Oversight - The management team will make investment decisions within the approved limits and timeframes, with the finance department responsible for execution [6][11]. - The company will adhere to relevant regulations and maintain transparency in its cash management activities, ensuring that the funds are not used for purposes other than those approved [7][12]. Impact on Operations - The cash management strategy is designed to not affect the normal operation of the company's fundraising projects or its main business activities, while also providing potential investment returns [9][10].

Core Viewpoint - The company plans to utilize part of its idle raised funds for cash management, not exceeding RMB 65 million, to enhance fund efficiency while ensuring the safety and proper use of the raised funds [1][4][14]. Fundraising Overview - The company raised a total of RMB 899.56 million from its initial public offering, with a net amount of RMB 810.66 million after deducting underwriting fees and other expenses [1][3]. - The funds are managed in a dedicated account, adhering to regulatory requirements [2]. Usage of Idle Funds - The company has identified a portion of the raised funds as temporarily idle due to the construction cycle of investment projects [3]. - The objective of using idle funds for cash management is to increase returns while ensuring that the investment projects are not affected [4][10]. Cash Management Details - The company will invest in low-risk, high-liquidity financial products, including but not limited to time deposits, structured deposits, and guaranteed income certificates [7]. - The investment period for these cash management activities will not exceed 12 months from the board's approval date [6]. Implementation and Oversight - The management team is authorized to make investment decisions within the approved limits and will be responsible for executing contracts related to cash management [7]. - The company will maintain transparency and adhere to disclosure obligations as per the Shanghai Stock Exchange regulations [8]. Profit Allocation - Any profits generated from cash management will be prioritized for investment in projects that may have insufficient funding, ensuring compliance with regulatory requirements [9]. Impact on Operations - The cash management plan is designed to not interfere with the company's normal operations or the execution of investment projects, while also aiming to enhance overall performance and shareholder returns [10]. Approval Process - The board of directors approved the cash management proposal on August 15, 2025, and it does not require shareholder approval [14]. Sponsor's Opinion - The sponsor, CITIC Securities, has expressed no objections to the cash management plan, confirming that it complies with relevant regulations and does not alter the intended use of the raised funds [14].

Core Viewpoint - The company plans to utilize part of its idle raised funds, not exceeding RMB 650 million, for cash management to enhance fund efficiency while ensuring the safety and proper use of the raised funds [1][4][6]. Fundraising Overview - The company raised a total of RMB 838.59 million from its initial public offering, with a net amount of RMB 810.66 million after deducting issuance costs [1][2]. - The funds are managed in a dedicated account, adhering to regulatory requirements [1][2]. Fund Utilization Plan - The net amount from the fundraising is RMB 810.66 million, with specific projects planned for investment [2][3]. - The company acknowledges that some of the raised funds may temporarily remain idle due to project timelines [3]. Cash Management Plan - The company intends to invest the idle funds in high-security, liquid, and capital-protected financial products, including but not limited to time deposits and structured deposits [4][6]. - The cash management period will not exceed 12 months from the board's approval date, allowing for rolling use of the funds within the specified limit [3][4]. Impact on Daily Operations - The cash management plan will not affect the company's normal operational cash flow or the execution of investment projects [4][6]. - The strategy aims to generate additional returns on idle funds, benefiting overall company performance and shareholder returns [4][6]. Approval Process - The board of directors approved the cash management proposal on August 15, 2025, without requiring shareholder meeting approval [6][7]. - The proposal complies with relevant regulations and internal management policies [6][7].

Core Viewpoint - Kangpeng Technology announced the approval of a proposal to use part of its idle raised funds for cash management, with a limit of up to RMB 650 million, ensuring that it does not affect the construction and use of the raised funds [2] Group 1 - The third meeting of the third board of directors will be held on August 15, 2025, to review the cash management proposal [2] - The company plans to invest in high-security, high-liquidity investment products with capital protection agreements [2] - The investment period for the cash management is set for 12 months from the date of board approval [2]

Group 1 - The company plans to use up to RMB 65 million of idle raised funds for cash management [1] - The funds can be used in a rolling manner within the specified limit [1] - The cash management will be conducted in different tranches with varying terms, not exceeding 12 months [1]

关于使用部分闲置募集资金进行现金管理的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 上海康鹏科技股份有限公司（以下简称"公司"）于 2025 年 8 月 15 日召开 第三届董事会第五次会议，审议通过了《关于使用部分闲置募集资金进行现金管 理的议案》，同意公司合理使用额度不超过人民币 65,000.00 万元的部分暂时闲 置募集资金进行现金管理，在确保不影响募集资金项目建设和使用、募集资金安 全的情况下，购买安全性高、流动性好、有保本约定的投资产品（包括但不限于 定期存款或大额存单、结构性存款、券商保本收益凭证等），使用期限为自董事 会审议通过之日起 12 个月内。在前述额度和期限范围内，资金可以循环滚动使 用。本事项无需提交股东会审议。保荐机构中信建投证券股份有限公司（以下简 称"保荐机构"）对本事项出具了明确的核查意见。具体情况公告如下： 证券代码：688602 证券简称：康鹏科技 公告编号：2025-046 上海康鹏科技股份有限公司 公司依照规定对募集资金采取了专户存储管理，开立了募集资金专户，与保 荐人、募 ...

Core Viewpoint - Kangpeng Technology, once a model of policy benefits in China's hard technology localization narrative, is now facing significant operational challenges, including declining profit margins and increased inventory impairment, leading to a potential capital exodus from the company [1][16]. Company Overview - Kangpeng Technology specializes in fine chemicals, focusing on the research, production, and sales of new materials, pharmaceuticals, and agricultural chemicals, with a strong emphasis on fluorinated fine chemicals [2]. - The company was recognized as a "specialized, refined, distinctive, and innovative" enterprise in Shanghai in 2021 and officially listed on the Sci-Tech Innovation Board in July 2023 [2]. Financial Performance - The company has experienced a dramatic reversal in performance post-IPO, with revenues declining for three consecutive years: 1.238 billion in 2022, 980 million in 2023, and 675 million in 2024, marking a 20.89% year-on-year decline in 2023 and a further 31.11% drop in 2024 [3]. - Gross margin has been on a downward trend since 2020, with an overall gross margin of only 12.65% in 2024, down nearly 30 percentage points from 2020, and significantly lower than 2023 [5]. - The new materials segment faced a gross margin of 2.7% in 2024, a decrease of 7.9 percentage points year-on-year, while the CDMO segment saw a gross margin of 23.17%, down 16.06 percentage points [5]. Expense Trends - Sales, management, and R&D expense ratios have all increased from 2022 to 2024, leading to a net profit decline of 37.58% in 2023 to 113 million, followed by a loss of 49.53 million in 2024, marking a 143.95% year-on-year decline [7]. - The net cash flow from operating activities also decreased sharply from 213 million in 2023 to 60.8 million in 2024 [9]. Business Risks - The Shanghai Stock Exchange has inquired about the significant changes in Kangpeng's new materials and CDMO business, as well as the increased inventory impairment provisions [11]. - The new materials business reported a gross margin of only 1.19% in Q1 2025, continuing a downward trend, with potential risks from market supply-demand changes and price declines [11]. - The CDMO business revenue fell by 48.29% in 2024 to 295 million, with a slight recovery in Q1 2025, but remains vulnerable to pricing pressures and market dynamics [12]. Market Position and Competition - Kangpeng's market share in the global LiFSI market was only 6% in 2023, significantly lower than competitors like Tianqi Materials (55%) and CATL's Times Technology (16%) [13]. - The company faces intense competition and pricing pressures, particularly from larger players who have integrated supply chains, leaving Kangpeng in a precarious position [13][14]. Future Outlook - The reliance on policy support and capital influx for growth may lead to value destruction, especially as the market environment evolves and competition intensifies [16].